Public health surveillance systems, programs and networks
In Canada, several groups share responsibility for public health surveillance. Most of the data comes through agreements with other departments and organizations, such as:
- regional health authorities
- federal, provincial and territorial partners
- private organizations like pharmaceutical companies
Surveillance system, program or network | Subcategory | Description |
---|---|---|
Antimicrobial Resistance Network (AMRNet) | Antimicrobial resistance | Conducts lab-based surveillance of antimicrobial resistance in bacterial and fungal pathogens. This surveillance program uses an integrated One Health approach that combines data from humans and animals. |
Blood Safety Contribution Program (BSCP) | Adverse events | Conducts surveillance activities for blood, tissue, and organ related adverse events in an effort to improve transfusion and transplantation safety. |
Canadian Acute Flaccid Paralysis Surveillance System (CAFPSS) | Childhood disorders and conditions, vaccine preventable | Monitors Canada's polio-free status by ensuring a sensitive, active surveillance system and prompt, appropriate investigation of acute flaccid paralysis cases to rule out the possibility of poliovirus infection. |
Canadian Antimicrobial Resistance Surveillance System (CARSS) | Antimicrobial resistance | Integrates data from 9 PHAC surveillance programs and its partners across human and agricultural sectors to support policy and programming to foster prudent antimicrobial use and to minimize antimicrobial resistance. |
Canadian Chronic Disease Surveillance System (CCDSS) | Chronic diseases and conditions, mental illnesses | Collects data on all residents who are eligible for provincial or territorial health insurance. It can generate national estimates and trends over time for over 20 chronic diseases and conditions, and other selected health outcomes. |
Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP) | Injuries and poisonings | Collects and analyzes data on injuries to people who are seen at the emergency rooms of 11 pediatric hospitals and 9 general hospitals in Canada. |
Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) | Antimicrobial resistance | Collects, analyzes and communicates trends in antimicrobial use and in antimicrobial resistance for select bacteria from humans, animals and retail meat across Canada. |
Canadian Measles and Rubella Surveillance System | Respiratory diseases, vaccine preventable | Conducts timely, ongoing, national monitoring of the circulation of measles, rubella, congenital rubella syndrome (CRS) and congenital rubella infections in Canada. |
Canadian Nosocomial Infection Surveillance Program (CNISP) | Antimicrobial resistance | Collects national epidemiologic and laboratory (molecular and resistance) data on various healthcare-associated infections, antimicrobial resistant organisms and hospital-level antimicrobial utilization. |
Canadian Paediatric Surveillance Program (CPSP) | Childhood disorders and conditions | Collects and studies information about rare childhood diseases and conditions from paediatricians across Canada. |
Creutzfeldt-Jakob Disease Surveillance System | Neurological diseases | Conducts prospective national surveillance for all types of human prion disease in Canada. |
Enhanced Surveillance of Antimicrobial-resistant Gonorrhea system (ESAG) | Antimicrobial resistance, sexually transmitted and blood-borne infections | Contributes to a better understanding of antimicrobial-resistant N. gonorrhoeae trends. It does this by linking a subset of antimicrobial-resistant gonorrhea laboratory data to enhanced epidemiologic and clinical data. There are currently 6 participating provinces and territories. |
National Laboratory Surveillance of Invasive Streptococcal Disease in Canada (eSTREP) | Antimicrobial resistance, bacterial infections | A passive, laboratory-based system monitoring invasive Streptococcus pneumoniae, Streptococcus pyogenes (group A streptococcus, GAS) and neonatal Streptococcus agalactiae (group B streptococcus, GBS). |
FluWatch: Canada’s National Influenza Surveillance Program | Respiratory diseases, vaccine preventable | Monitors the spread of respiratory viruses and influenza-like illnesses year-round, the FluWatch+ surveillance system monitors the progression and severity of respiratory viruses. |
FoodNet Canada | Enteric diseases | Supports activities that will reduce the burden of enteric disease through comprehensive sentinel site surveillance implemented through local public health units and provincial public health laboratories. |
Gonococcal Antimicrobial Surveillance Program Canada (GASP-Canada) | Antimicrobial resistance, sexually transmitted and blood-borne infections | A voluntary laboratory-based national surveillance system that monitors antibiotic resistant Neisseria gonorrhoeae. It also monitors resistance trends, characterizes N. gonorrhoeae collected across Canada and supports outbreak investigations. |
HIV and AIDS Surveillance | Sexually transmitted and blood-borne infections | Routine and enhanced surveillance and estimates of HIV incidence, prevalence and engagement across the HIV care continuum support monitoring of HIV and AIDS in Canada, including progress towards global elimination targets. |
Human Emerging Respiratory Pathogens Bulletin | Respiratory diseases | Serves as a mechanism for information sharing on summary surveillance indicators of global active public health events affecting humans in the field of emerging respiratory pathogens. |
IMPACT, Canada's Immunization Monitoring Program ACTive | Adverse events, vaccine preventable | A paediatric hospital-based national active surveillance network for adverse events following immunization, vaccine failures and selected infectious diseases that are, or will be, vaccine preventable. |
International Circumpolar Surveillance System of Invasive Bacterial Diseases | Bacterial infections, respiratory diseases, vaccine preventable | Monitors infectious diseases in countries with Arctic regions. It does so through a network of hospitals and public health offices in countries with Arctic regions. |
Lyme Disease Enhanced Surveillance System | Zoonotic diseases | Monitors Lyme disease to keep track of the number of human cases of Lyme disease, identify areas where blacklegged and western blacklegged tick populations may be emerging and identify the areas where people are most at risk of Lyme disease. |
Mpox Surveillance | Zoonotic diseases, sexually transmitted and blood-borne infections | Conducts public health monitoring of mpox cases reported by provincial and territorial public health authorities on a regular basis, contributing to global monitoring initiatives and watching for the emergence of clade I mpox virus in Canada. |
National Enhanced Invasive Meningococcal Disease Surveillance System | Bacterial infections, vaccine preventable | Captures bacteriologic information on invasive meningococcal disease cases for the purpose of describing annual trends, in particular serogroup trends. Enhanced surveillance provides important information for immunization recommendations, vaccine programs and health policies in Canada. |
National Enteric Surveillance Program (NESP) | Enteric diseases | Provides timely analysis and reporting of laboratory confirmed enteric disease cases in Canada. This includes major enteric bacterial pathogens, intestinal parasitic organisms, and enteric viruses. |
Notifiable Diseases Online | Infectious diseases | An interactive website that enables users to explore annual data from the Canadian Notifiable Disease Surveillance System (CNDSS). The CNDSS monitors trends in nationally notifiable diseases, infectious diseases that have been identified collectively by the federal, provincial and territorial governments as priorities for monitoring and control. |
Opioid- and Stimulant-related Harms Surveillance System | Adverse events, substance use | Shares data and monitors fatal and non-fatal harms related to opioids and stimulants across the country. |
Respiratory Virus Detection Surveillance System (RVDSS) | Respiratory diseases | Collects the number of tests and positive detections for 8 respiratory viruses from laboratories across Canada. |
Sexually Transmitted and Blood-borne Infections Surveillance | Sexually transmitted and blood-borne infections | Conducts routine and enhanced surveillance of nationally notifiable sexually transmitted and blood-borne infections (STBBI), including chlamydia, gonorrhea, syphilis, hepatitis B, hepatitis C, and HIV and develops population estimates of STBBI incidence, prevalence and engagement in care. |
Canadian Tuberculosis Laboratory Surveillance System (CTBLSS) | Antimicrobial resistance, respiratory diseases, vaccine preventable | Monitors drug resistance to tuberculosis across Canada by collating information provided from provinces and territories on samples tested for tuberculosis. |
Wastewater monitoring | Infectious diseases | Collects community or institutional sewage samples and test them to detect specific diseases or other public health threats. This provides community health data about the levels of disease over time. |
Mosquito-borne Disease Surveillance | Zoonotic diseases | Monitors mosquito-borne diseases throughout the year using a One Health approach. Provides the most recent data for humans, mosquito pools, and other animals reported to PHAC. |
Related links
What we do
- How the Public Health Agency of Canada gathers and uses data
- Programs and policy development – Public Health Agency of Canada
Privacy
- Privacy and the Public Health Agency of Canada
- How the Public Health Agency of Canada protects privacy
Transparency
Page details
- Date modified: